The European Medicines Agency (EMA) on Monday said it would review safety data for third- and fourth-generation birth control pills, responding to French concern that these contraceptives may cause dangerous blood clots. The agency, describing contraceptive pills as carrying only “a very rare…
Visit site:
EU drug agency to review new birth control pills for blood clot risk
Print 
PDF
